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Methanol, a potential feedstock for 
biotechnological processes 
Lubbert Dijkhuizen, Theo A. Hansen and Wim Harder 
A wide variety of bacteria and yeasts is able to grow in inexpensive 
synthetic media  with methanol  as the sole or major  source of  carbon 
and energy. This is due to the presence of  a few unique enzymes  which 
enable these organisms to generate metabol ic  energy and synthesize 
cell constituents f rom this one-carbon substrate. In the chemica l  indus- 
try there is currently much interest in the production of  fuels and 
chemicals  f rom methanol .  As a feedstock for industrial fermentat ions 
methanol  is also attractive because of  its low cost, ease of  handling and 
abundant availabil ity. In many countries methanol-ut i l iz ing microbes 
are being studied and their potential util ity in biotechnological  pro- 
cesses is explored. These studies are a imed at making use of  their 
characterist ic propert ies,  exploit ing known organisms and new strains 
for improving existing processes and developing novel products. 
Methanol is a one-carbon compound 
which can be made from synthesis gas, 
a mixture of carbon monoxide and 
hydrogen. Most synthesis gas is cur- 
rently manufactured bysteam reform- 
ing of natural gas, but alternative 
sources are coal and (residual) oil. In 
the chemical industry there is 
increasing interest in methanol both as 
an alternative source for the produc- 
tion of chemicals commonly derived 
from ethylene, and as a fuelL This 
interest is based on economic con- 
siderations (i.e. the low price of 
methanol (6 c/lb) and the billion-gal/yr 
surplus capacity for its production in 
the world) and on technological 
innovations which allow the produc- 
tion of such important industrial 
chemicals as vinylacetate, ethylene gly- 
col and ethanol via new routes from 
methanol as a feedstockL The sig- 
nificance of these new technologies i  
that they provide a direct route from 
coal to derivative industrial chemicals, 
thereby circumventing dependence on 
crude oil. 
As an alternative to chemical pro- 
cesses, methanol and other one-carbon 
compounds can also be converted into 
a variety of products by biological 
processes. These processes use micro- 
organisms which can grow on one- 
carbon compounds as the sole or major 
source of carbon and energy. These 
organisms possess, in addition to the 
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metabolic machinery common to most 
living cells, a number of unique 
enzymes that enable them to generate 
energy from methanol and synthesize 
all cell constituents required for 
growth and reproduction from this C~ 
carbon source. This means that they 
are able to synthesize from methanol a 
variety of carbon compounds (similar 
to that produced by organisms current- 
ly used in the fermentation i dustry) 
from more complex and more expen- 
sive carbon sources. It is this ability of 
methylotrophs that is the main reason 
for the current interest in the appli- 
cation of these organisms in biotech- 
nological processes. Initially this 
interest mainly focused on the produc- 
tion of single-cell protein (SCP) from 
methanol, but more recently it has 
turned towards the production of use- 
ful chemicals. Compared to chemical 
processes, the use ofmethylotrophs in 
bioprocesses has the added advantage 
that multi-step reactions for the 
synthesis of complex materials under 
ambient process conditions are 
feasible. 
In this review we will concentrate on 
potential opportunities offered by 
methanol-using organisms. For infor- 
mation on methane-utilizing or 
methane-generating organisms the 
reader is referred to recent reviews 2 4. 
For the present discussion it may suf- 
rice to briefly mention that methanol 
has distinct advantages over methane 
as a feedstock of biotechnological 
processes. This is not only due to 
physical and chemical considerations 
(i.e. methanol is completely miscible 
with water, is easy to store, to transport 
© 1985, Elsevier Science Publishers B.V., Amsterdam 0166 94301851502.00 
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and to handle), but also to the pro- 
perties of the pertinent organisms. 
Compared to methane, aerobic pro- 
cesses based on methanol usually show 
higher rates and higher yields of for- 
mation of carbon products and have a 
lower oxygen demand. Furthermore, 
methanol is used by a number of 
fermentative anaerobes, whereas 
methane isnot. 
As outlined below, the metabolic 
pathways of methanol metabolism are 
largely known and this permits an 
analysis of the potential utility of 
methylotrophs. From this analysis a 
number of questions arise which point 
the way to future research on these 
interesting organisms. 
Physiology ofmethy lot rophs 
The metabolism of methylotrophs 
has been intensively researched during 
the last two decades and this has 
resulted in the accumulation of a 
wealth of information in the recent 
literature 517. A general picture of 
methanol metabolism is drawn in this 
section and, when relevant to possible 
biotechnological applications, unique 
features of methylotrophic micro- 
organisms are emphasized. 
Aerobic methanol-utilizing bacteria and 
yeasts 
Over the years it has become clear 
that methylotrophs possess special 
pathways both for the generation of 
energy and for carbon assimilation. 
Oxidation of methanol proceeds via 
formaldehyde to CO 2 (Fig. 1). In bac- 
teria this involves a methanol dehyd- 
rogenase, whose prosthetic group was 
originally identified in Hyphomicro- 
bium X as pyrroloquinoline quinone. 
(A) 
1 2 3 
CHaOH-~HCHC)~, ~ HCOOH~ C02 
PQQH2 2H NADH2 
(B) 02 GSH 
CHaOH~4 .C.O ~ 5 6 
H202 NADHz NADHa 
Fig. I. Pathways for methanol oxidation in 
bacteria (A) and yeasts (B). I: methanol 
dehydrogenase; 2: formaldehyde dehydro- 
genase; 3: formate dehydrogenase; 4" alcohol 
oxidase; 5: glutathione-dependent formal- 
dehyde dehydrogenase; 6: formate dehydro- 
genase (for details: see text). 
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or xylulosemonophosphate (XuMP) 
cycle, Fig. 3, has only recently been 
elucidated. 
Fig. 2. Cells 0fHansenula polymorpha, grown in a methanol-limited chemostat at a dilution rate 
of D = O. 05 h - t, closely packed with several cubically shaped peroxisomes ( A ; fixation KMn0 4) . 
Alcohol oxidase activity in the organelles is demonstrated after incubation of glutaraldehyde- 
fixed spheroplasts of these cells with CeCI3 and methanol. Note hat the crystalline substructure 
of the peroxisomal matrix is well preserved under these conditions (B; fixation glutaraldehyde- 
OsO4). The markers represent I lam. Courtesy of M. Veenhuis. 
This novel coenzyme isalso present in 
several other pyridine nucleotide- 
independent dehydrogenases in both 
methylotrophs and non-methylo- 
trophs. In all methanol-utilizing yeast 
species investigated so far the con- 
version of methanol into formaldehyde 
(and H~O2) is catalysed by alcohol 
oxidase. This enzyme has been puri- 
fied from Hansenula polymorpha and 
Candida boidinii amongst others and 
consists of eight identical subunits 
each containing one molecule of FAD. 
In these two organisms, alcohol oxi- 
dase and catalase are exclusively loca- 
ted in microbodies (peroxisomes; ee 
Fig. 2) and high levels of alcohol 
oxidase (up to 30% of the total soluble 
protein) are synthesized under 
methanol-limiting conditions. 
The formaldehyde produced from 
methanol can be further oxidized in 
several ways. In bacteria this may 
occur via an NAD-(in)dependent for- 
maldehyde dehydrogenase or (in 
serine-pathway organisms, see below) 
via enzymes of the methenyltetra- 
hydrofolate pathway. The formate 
produced is finally converted into CO 2 
via NAD-dependent formate dehydro- 
genase. Another possible mechanism 
for complete oxidation of for- 
maldehyde into CO2, present only in 
methane non-utilizing bacteria with 
the RuMP cycle (see below), involves a
cyclic sequence of reactions in which 
enzymes of the oxidative pentose- 
phosphate pathway (glucose-6-phos- 
phate dehydrogenase/6-phosphoglu 
conate dehydrogenase) play an im- 
portant role. This pathway does not 
require formaldehyde and formate 
dehydrogenase activities. In yeasts, an 
NAD/glutathione-dependent for- 
maldehyde dehydrogenase is exclu- 
sively involved in formaldehyde oxida- 
tion. The product of this reaction, 
S-formylglutathione, is further meta- 
bolized to CO2 via either a hydrolase 
and an NAD-dependent formate 
dehydrogenase, or directly via the 
latter enzyme. 
In aerobic methylotrophs carbon as- 
similation proceeds initially by con- 
version of three C1 units into a C 3 
compound via a cyclic pathway. In 
bacteria three of these pathways are 
now firmly established, namely the 
ribulosebisphosphate (RuBP) or Cal- 
vin cycle (e,g. in Paracoccus denitrifi- 
cans, Xanthobacter autotrophicus), the 
ribulosemonophosphate (RUMP) 
cycle (e.g. in Pseudomonas methanica, 
Methylophilus rnethylotrophus), Fig. 3, 
and the serine pathway (e.g. in 
Pseudomonas AM1; Hyphomicrobium 
X), Fig. 4. The assimilation pathway in 
yeasts, the dihydroxyacetone (DHA) 
The Calvin cycle in methylotrophs 
It is clear from Fig. 3 that the three 
pathways involving sugar phosphate 
molecules as intermediates are very 
similar in design. The main differences 
are found in the identity of the enzymes 
specifically involved in the initial reac- 
tions by which the C 1 units are fixed, 
namely ribulosebiphosphate carboxyl- 
ase/phosphoribulokinase (RuBP 
cycle), hexulosephosphate synthase/ 
hexulosephosphate isomerase (RUMP 
cycle) and dihydroxyacetone synthase/ 
dihydroxyacetone kinase (XuMP 
cycle). Further steps in these cycles are 
catalysed by enzymes from the glyco- 
lytic or Enmer-Doudoroff pathways 
(i.e. fructosebisphosphate aldolase, 
FBPA, or 2-keto-3-desoxy-6-phospho- 
gluconate aldolase, KDPGA, respec- 
tively) and the oxidative pentosephos- 
phate pathway involving either sedo- 
heptutosebisphosphatase (SBPase) or 
transaldolase (TA). Based on the 
various possible combinations of these 
enzyme systems, three variants of the 
RuMP cycle have been encountered in 
different methylotrophic bacteria 
(Table 1). 
The serine pathway 
Intermediates ofthe serine pathway 
are mainly organic acids and amino 
acids. Enzymes pecifically involved in 
this pathway are serine transhydroxy- 
methylase, serine:glyoxylate amino- 
transferase and hydroxypyruvate 
reductase. Further steps in this 
pathway are catalysed by enzymes of 
the citric acid cycle. In most serine 
pathway organisms the glyoxylate 
cycle enzyme, isocitrate lyase, is absent 
and the identity of the enzymes 
involved in the regeneration of gly- 
oxylate remains to be established. 
Table I. Metabolic energy required for the conversion of C-units into C 3 compounds 
Cycle C 1 units Primary Variant A TP NAD(P)H 2 
fixed product required required 
RuBP 3CO 2 PGA SBPase 8 5 
RuMP 3HCO GAP FBPA/TA 1 0 
GAP FBPA/SBPase 2 0 
pyruvate KDPGA/TA 0 - 1 
serine 2HCHO 
+ 1CO 2 PGA icl ÷ 3 2 
XuMP 3HCO GAP SBPase 3 0 
For abbreviations: see legend Fig. 3, and SBPase: sedoheptulosebisphosphates; FBPA: fructose- 
bisphosphate ldolase; TA: transaldolase; KDPGA: 2-keto-3-desoxy-6-phosphogluconat e ald lase; 
icl+: isocitrate lyase positive. 
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(~) 3 CO2 
\ 
3 Ru BP 
ATP ~ 
3 RuMP " 
® 3 HCHO 
3 RuMP ~k~ 
-- 6 PGAf  
6 ATP 
6 NADH2 
--- FMP + FMP+ GAP 
.Ru BP cycle of carbon dioxide fixation 
• 3HUMP ,, FMP+FMP+FMP I 
I FBP 
Ru MP cycle of formaldehyde fixation 
(~ 3 HCHO 
3XuMP ~ 
3 GAP ) 
3 ATP 
FMP + FMP + GAP 
~- DHA cycle of formaldehyde fixation .. 
Fig. 3. Schematic representation of the Calvin cycle (A), the ribulosemonophosphate cycle (B) 
and the dihydroxyacetone or xylulosemonophosphate cycle (C). RuBP: ribulose-l,5- 
bisphosphate; RUMP: ribulose-5-phosphate; PGA: 3-phosphoglycerate; GAP: glyceraldehyde- 
3-phosphate; FMP: fructose-6-phosphate; HUMP: 3-hexulose-6-phosphate; FBP: fructose- 
1,6-bisphosphate; XuMP: xylulose-5-phosphate; DHA: dihydroxyacetone; DHAP: 
dihydroxyacetone phosphate. 
Depending on the type of assimi- 
lation pathway, a large variation can be 
observed in the metabolic energy 
required for synthesis of the primary 
C 3 output molecule. This is also sum- 
marized in Table 1 and the data show 
that the RuMP cycle is energetically 
the most efficient, followed by the 
XuMP cycle in yeasts. These dif- 
ferences are reflected in the experi- 
mental growth yields observed in 
organisms growing on methanol, and 
range from around 0.55 g dry weight (g 
methanol)-~ in RuMP cycle organisms 
to 0.37-0.45 g g-~ in serine pathway 
organisms and yeasts. The fact that he 
growth yield in the latter organisms i
in the same range as for bacteria using 
the serine pathway is due to the invol- 
vement of an oxidase in the conversion 
of methanol to formaldehyde. 
Anaerobic methanol-utilizing bacteria 
Obligately anaerobic methanol- 
using bacteria are found among the 
methanogenic and the acidogenic bac- 
teria. Methanogenic bacteria such as 
Methanosarcina barkeri convert meth- 
Trends in Biotechnology, I7ol. 3, No. 10, 1985 
anol to CH4 and CO2 (for equations see 
Table 2); their growth is slow and 
molar growth yields on methanol are 
low. Acidogenic bacteria that grow on 
methanol were first described in 1980 
(Butyribacterium methylotrophicum); 
six additional species have since been 
shown to grow on methanol with the 
formation of organic acids as major 
fermentation products (Table 3). Some 
of these bacteria have been known for 
several years but their methylotrophic 
potential had remained undiscovered. 
Methylotrophic acidogens have been 
the subject of some excellent recent 
reviews 3'16'17. Most methylotrophic 
acidogenic bacteria can also use other 
Cl-compounds such as H2 + CO 2 and 
carbon monoxide. Betaine and choline 
also function as Cl-substrates for 
strains of Eubacterium and limosum, but 
in this process only one of the methyl 
groups is utilized and this results in 
the formation of N~N-dimethylgly- 
cine and N,N-dimethylethanolamine, 
respectively. Similarly, growth of 
Acetobacterium woodii on several meth- 
oxylated aromatic compounds is, in 
fact, methylotrophic since only the 
methoxy groups are used. None of the 
methanol-using acidogens, however, is
metabolically restricted to C~-sub- 
strates for energy generation; all grow 
on a variety of other substrates 
including some sugars. Most of the 
acidogens form acetate from methanol 
(reaction b in Table 2). Butyribac- 
terium methylotrophicum, however, 
forms butyrate as the main product and 
so does Eubacterium limosum. The 
latter species forms small amounts of 
caproate in addition. During growth of 
both species on H 2 + COs, or on CO, 
acetate isby far the major product. 
Organisms uch as Butyribacterium 
methylotrophicum have been shown to 
grow in minimal media supplemented 
with vitamins i so that they can derive 
virtually all of their cell carbon from 
C~-substrates. The most likely path- 
]'3-Phosphoglyc~rale ] 
T 
2 Sorine Phasphoenolpyruvate 
2 Glycine 




Fig. 4. The serine pathway (icl+-variant). 
Reproduced from Ref. 14 with permission. 
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way of cell carbon synthesis is via 
acetyl-CoA. Studies on the bio- 
chemical pathway of the homoacetate 
fermentation have mainly been per- 
formed with Clostridium thermo- 
aceticum as a model organism. This 
organism is usually grown on sugars 
and forms three moles of acetate per 
mole of the C6-sugar utilized. Growth 
on H2 + CO2 and on CO, but not on 
methanol, has been documented. The 
pathway of acetate formation in 
Clostridium thermoaceticum is shown 
which may also function as a CO2 
reductase. The detailed mechanism of 
the formation of the acetyl-group from 
CH3-tetrahydrofolate nd CO (or CO2 
and H2) is being studied; rapid progress 
is to be expected, however, since Hu et 
ado reported the synthesis of acetyl- 
CoA from CO, CH3-tetrahydrofolate, 
CoA and ATP in the presence of a puri- 
fied methyltransferase, CO dehydro- 
genase, a purified corrinoid protein 
and an enzyme X with a hitherto un- 
known function. Recently 21, evidence 
Table 2. Some reactions involving anaerobic conversions of C I-compounds 
Reaction AG 0' 
ky 
(a) 4CH3OH --~ 3CH 4 + HCO 3- + H + + H 2 
(b) 4CH3OH + 2HCO 3- ~ 3acetate- + H ÷ + 4H20 
(c) 4CH3OH + 0.8 HCO 3- ~ 1.2butyrate- + 0.4H + + 4H20 
(d) 4H 2 + H ÷ + 2 HCO 3- ~ acetate- + 4H20 
(e) 4CO + 4H20 --~ acetate- +2HCO3-+ 3H + 
-314 .8  
-221 .8  
-216 .7  
- 104.6 
- 165.4 
in Fig. 5. Although enzyme measure- 
ments and ]3C NMR studies ~9 per- 
formed with Acetobacterium woodii, 
Clostridium thermoautotrophicum and 
Butyribacterium methylotrophicum 
support he outline of the mechanism 
of acetate formation as depicted in Fig. 
5, several details of this scheme remain 
to be elucidated. A central role is 
played by carbon monoxide dehydro- 
genase. 
This enzyme was purified from 
Clostridium thermoaceticum and Aceto- 
bacterium woodii and shown to contain 
iron-sulfur clusters and nickel. It is 
thought to be involved in the reduction 
of CO2 to an intermediate at the level of 
CO, and in the activation of CO. The 
methyl group of acetate isformed from 
CO2 via C1-tetrahydrofolates during 
growth on CO2 + H2 or CO. In the 
initial step of this series of reactions a
formate dehydrogenase is involved 
was presented for the view that CO 
dehydrogenase is the condensing 
enzyme that forms acetyl-CoA from its 
component parts. 
It remains to be established exactly 
how methanol enters the pathway to 
acetate (or butyrate). In Eubacterium 
limosum, methanol metabolism is ini- 
tiated by a reaction with a methyltrans- 
ferase (MT1) which contains firmly 
bound cobalamin 22. Formation of 
butyrate should probably be regarded 
as a variant of acetate formation in that 
acetyl-CoA is reduced to butyrate. 
Methylotrophs and biotechnology 
In industrial fermentations the price 
of the feedstock is of crucial impor- 
tance in determining the economic via- 
bility of the process. In view of the low 
cost of methanol and its availability in 
large amounts in a very pure form, it is 
an attractive alternative substrate. The 
butyrate acetate  
i i i r 
CH3-'I'HF~.~,~ /~ E[Co]~ / /~CH3~-SCoA~CHa~I=O-(~)  
\ /  \ /  o / o 
methylene-THF ~. .~_  _ _ ~1 / ~ HaPO 4 
"nethenyI-THF THF~V/ ~'-~ E[Co] j I ~ f  0]'' " 
formyl-THF - ~ HCOOH' C02 
Fig. 5. Pathway of acetate and butyrate formation in anaerobic, acidogenic bacteria growing on 
C ~-substrates. THF: tetrahydrofolate; E[ Co] : corrinoid protein. 
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possession of unique sets of enzymes 
enables methylotrophic microorgan- 
isms to convert methanol into 
compounds containing carbon- 
carbon bonds. The products of these 
primary carbon assimilation reactions 
can subsequently be used in further 
biosynthetic pathways o that all the 
monomers and polymers required for 
cell growth and multiplication can be 
synthesized from the C] substrate. 
For an aerobic methylotrophic bac- 
terium using the FBPA/TA variant of 
the RuMP cycle it can be calculated 
that the conversion of methanol into a 
hexosemonophosphate occurs accord- 
ing to the following stoichiometry: 
6 methanol + 6 PQQ + 2 ATP 
glucose 6-phosphate + 6 PQQH 2 + 
2 ADP + 2P~. 
The 6 moles of methanol and one 
mole of glucose, approximately equi- 
valent on a weight o weight basis, are 
also very similar bioenergetically. A 
major problem of using these aerobic, 
methylotrophic organisms in indus- 
trial processes, however, is their high 
oxygen demand since the reduction 
equivalent (PQQH2) produced in the 
above reaction must be reoxidized. In 
this respect he anaerobic, acidogenic 
methylotrophic bacteria offer an 
attractive alternative. 
Despite the feasibility and the econo- 
mic attraction of using methanol as a 
replacement feedstock in industrial 
fermentations, potential processes 
should be selected carefully. First of all 
it is clear that, for established pro- 
cesses, achange to methanol involving 
selecting and breeding amethylotroph 
as a novel production strain, can only 
be considered if the cost of the fermen- 
tation broth is relatively high 
compared to the value of the product. 
Thus, research on potential biotechno- 
logical applications based on methanol 
as a cheap feedstock should be aimed 
mainly towards the production of bulk 
chemicals and not towards high added- 
value products uch as hormones and 
proteins of medical or veterinary 
importance. A second reason for con- 
sidering methanol as a feedstock may 
be that using a methylotroph opens up 
new metabolic routes for the synthesis 
of various products. Thirdly, an 
advantage may be gained from the 
unique properties and metabolism of 
methylotrophs thereby exploiting 
their potential use as vehicles for the 
expression of heterologous genes, as 
266 
Table 3. Anaerobic methanol-using ocidogenic 
bacteria 











Eubacterium limosum butyrate 
Sporomusa ovata acetate 
Sporomusa sphaeroides acetate 
novel biocatalysts and in the produc- 
tion ofmetabolites. 
Practical application of 
methylotrophs 
Judging from the large number of 
patents covering many presumptive 
processes involving methylotrophs 23 
there is currently wide interest in this 
area of biotechnological research 
(Table 4). However, to our knowledge 
only a limited number of processes 
has been realized. Early on the 
main emphasis was on the production 
of single-cell protein using bacteria 
(i.e. Methylophilus methylotrophus, 
Methylomonas clara) or yeasts (Pichia 
pastoris) growing aerobically on 
methanol. The various parameters of 
importance in these processes have 
been studied extensively 5'7's and at the 
moment plants are operating in a 
number of countries. The economics 
of these processes, however, are 
strongly dependent on the fluctuations 
in the price of alternative protein 
sources and suffer from the restricted 
market for SCP. Interest is now turn- 
ing more and more towards the pro- 
duction of metabolites and primary 
products, such as polysaccharides, 
amino acids, vitamins and co- 
enzymes 24. Research in this direction is 
still mainly at the stage of selection of 
suitable strains and their further 
improvement via conventional breed- 
ing techniques. 
It can be predicted that the greatest 
advantage of methanol as a feedstock 
will be in those processes which aim to 
use specific properties of methanol 
metabolism. This is reflected in the 
current interest in the production of 
serine using serine pathway organisms 
and of aromatic amino acids (via 
erythrose-4-phosphate and PEP) with 
RuMP cycle methylotrophs. With res- 
pect to vitamins and coenzymes the 
most promising prospects appear to be 
riboflavin and vitamin Bt2 , both of 
which are synthesized at high rates 
under certain growth conditions in 
yeasts (riboflavin) and both anaerobic 
and aerobic bacteria (vitamin B12), 
respectively. Furthermore, the pos- 
sible application of the novel biocata- 
lysts encountered in methylotrophs, in 
enzyme electrodes, fuel cells and for 
cofactor regeneration, are being 
investigated extensively. 
Finally use can be made of other 
specific properties of methylotrophs. 
For example, under certain conditions 
alcohol oxidase constitutes up to 30% 
of the total soluble protein in peroxi- 
somes of methylotrophic yeasts. The 
potential of these organisms as vehicles 
for expressing foreign genes and for 
packaging foreign proteins in subcel- 
lular organelles where they are pro- 
tected against proteolysis i currently 
being investigated. 
Anaerobic methylotrophic bacteria 
Given the high oxygen demand of 
aerobic methylotrophic bacteria, the 
anaerobic, acidogenic methylotrophic 
bacteria might be thought o be more 
suitable for the production of organic 
acids such as acetate and butyrate, the 
end-products of the fermentative pro- 
cesses in these organisms. Acetate, 
however, is already produced effi- 
ciently on a large scale from methanol 
and CO by the chemical industry/and 
it seems unlikely that a biotech- 
nological process could become com- 
petitive. 
Table 4. Potential use  of methylotrophs in 
bioprocesses 
Single-cell protein enzyme lectrodes 
Polysaccharides fuel cells 
Amino acids cofactor egeneration 
Vitamins coenzymes 
Similarly, while butyrate can easily 
be esterified (the possible uses of 
methyl and ethyl esters of butyrate 
have been discussed by Zeikus 3) sig- 
nificant advances in the fermentation 
of methanol to butyrate and in sepa- 
ration processes would be needed 
before biotechnological butyrate pro- 
duction could emerge as a commercial 
success  3'25'26. Such  constraints might 
also apply to the production ofpropio- 
nate. Reduction of acetate + CO 2 by 
hydrogen to propionate is catalysed by 
Desulfobulbus propionicus27; mixed cul- 
Trends in Biotechnology, Vol. 3, No. 10, 1985 
tures or two-stage cultures of an aceto- 
genic methanol-fermenting bacterium 
and Desulfobulbus, therefore, offer, at 
least theoretically, a way of producing 
propionate from methanol. 
The anaerobic, acidogenic methylo- 
trophic bacteria might provide a 
source of other commercially interest- 
ing compounds, however. Up to 28% 
of the methanol carbon is recovered in
cell carbon during growth of Buty- 
ribacterium methylotrophicum on 
methanol, a value which is consider- 
ably lower than during growth of 
aerobes on methanol (see above). This 
is not unexpected in view of the far 
smaller energy gain in acidogenesis a
compared with oxidation of methanol 
to CO 2. The anabolic process requiring 
most ATP is protein synthesis. The 
synthesis of central intermediates of 
carbon metabolism from methanol and 
CO2, however, can be carried out with 
only modest investments ofATP and, 
therefore, production in reasonable 
yields of amino acids, for instance, 
should in principle also be possible 
with anaerobes. Acidogenic methylo- 
trophs have been known for only five 
years. It is therefore not surprising that 
so far relatively few studies have dealt 
with possible applications of these 
microbes. 
Conclusions 
Recent advances in our under- 
standing of the physiology and bio- 
chemistry of methylotrophs have 
made it possible, at least in principle, to 
evaluate their potential in biotech- 
nological processes. The range of 
organisms with interesting and 
promising properties is continuously 
increasing and it is to be expected that 
they will find specific applications in 
bioprocesses based on methanol as a 
feedstock. Although the metabolic 
pathways of methanol metabolism are 
largely known, our current level of 
understanding of the regulation of 
metabolic fluxes in methylotrophs, 
particularly those leading to useful 
products, is less well developed. This 
is currently the main focal point of 
research and one which is essential 
for the development of future bio- 
technological processes based on 
methanol. 
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Plasma protein fractionation 
E. R. A. Jeans, P. J. Marshall and C. R. Lowe 
The fractionation of blood plasma yields a number of therapeutic 
proteins which together constitute a billion dollar world-wide market. 
Conventional plasma fractionation procedures are being replaced by 
more sophisticated chromatographic techniques. The application of 
genetic engineering and these new downstream processing techniques is 
likely to lead to improved products of higher purity and stability, with 
less likelihood of contamination by viruses and at lower cost per 
therapeutic dose. 
Whole blood plasma contains 
numerous proteins of potential thera- 
peutic, and hence, economic value. 
Separating or fractionating these 
plasma proteins not only enables the 
treatment ofseveral patients using any 
given blood sample but also upgrades 
the potency of the resulting proteins to 
many times that of whole plasma. For 
example, a factor VIII concentrate, 
which contains at least 15-times the 
normal plasma concentration f clot- 
ting factor VIII, is routinely used in the 
control of bleeding in haemophiliacs. 
Most of the amenable clinical condi- 
tions are treated by replacement with 
the appropriate plasma protein concen- 
trate either as a prophylactic or after 
injury. For example, albumin is widely 
used as a blood-volume expander, after 
blood loss as a result of surgery, acci- 
dent or post-partum haemorrhage. 
Similarly, the most commonly used 
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immunoglobulins are anti-Rh(D) as a 
prophylactic for Rh allo-immunization 
in pregnancy, auti-tetanus and anti- 
rubella 1. The physiological nd clinical 
properties of these and other proteins of 
current commercial interest are sum- 
marized in Table 1. 
World market 
Economically, albumin and factor 
VIII are the most important plasma 
proteins, with world market values 
ranging from $250 million-750 million 
for albumin and $200 million-275 mil- 
lion for factor VIII. Immunoglobulins 
are used extensively in some countries 
such as Germany and Japan, and repre- 
sent $300 million-500 million on the 
world market 6. Albumin, which 
accounts for about 38% of the total 
world market in plasma proteins, sells 
at $2.50 per gram with an average dose 
of 12.5 g costing $30-35. Factor VIII 
represents 18% of the market and, if it 
were available as a homogeneous prep- 
aration, would be considerably more 
expensive at $500 000 per gram (7-14 
US cents/unit of activity). An average 
dose of 250 units contains only 12.5/~g 
of factor VIII protein and costs $17-35. 
In Europe, however, factor VIII is 
more expensive at 30 US cents/unit or 
$75 per 250 unit dose. The largest col- 
lector, processor and exporter of 
plasma nd plasma-derived products is 
the USA. According to the American 
Blood Resources Association 6, of the 
9.5 x 106 litres of plasma consumed 
annually world-wide, the USA collects 
a total of 7.7 x 106 litres via volunteers 
and the plasma industry. 
The USA, Germany and Japan are 
the major consumers of plasma and 
plasma-derived products, between 
them consuming 65% of the total world 
market in 1980, which was then esti- 
mated at $1.2 billion; on the assump- 
tion that the market increases by 10% a 
year, it could now be worth a staggering 
$1.75 billion. 
Cohn fractionation 
In 1946, a process was devised for the 
fractionation of plasma proteins 7.The 
Cohn procedure was based on the dif- 
ferential precipitation of the various 
proteins by appropriate combinations 
of ethanol concentration, low tempera- 
tures, ionic strength, pH and total pro- 
tein concentration. The conditions 
used for obtaining the Cohn fractions 
and their constituents are summarized 
in Table 2. Over the years, numerous 
improvements have been made to the 
Cohn procedure to enhance the 
economy of production and purity of 
the relatively few proteins used in large 
quantities in clinical practice, i.e. 
albumin, immunoglobulins and factor 
VIII. Not surprisingly, therefore, most 
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